PetIQ Inc (PETQ)
17.04
+0.20
(+1.19%)
USD |
NASDAQ |
May 03, 16:00
17.02
-0.02
(-0.09%)
After-Hours: 20:00
PetIQ SG&A Expense (Quarterly): 42.73M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 42.73M |
September 30, 2023 | 55.02M |
June 30, 2023 | 55.16M |
March 31, 2023 | 43.33M |
December 31, 2022 | 37.75M |
September 30, 2022 | 45.98M |
June 30, 2022 | 50.60M |
March 31, 2022 | 48.24M |
December 31, 2021 | 41.46M |
September 30, 2021 | 45.25M |
June 30, 2021 | 43.14M |
March 31, 2021 | 40.67M |
December 31, 2020 | 32.63M |
September 30, 2020 | 35.56M |
June 30, 2020 | 38.49M |
March 31, 2020 | 31.69M |
Date | Value |
---|---|
December 31, 2019 | 28.87M |
September 30, 2019 | 29.34M |
June 30, 2019 | 24.45M |
March 31, 2019 | 20.54M |
December 31, 2018 | 18.73M |
September 30, 2018 | 17.62M |
June 30, 2018 | 16.94M |
March 31, 2018 | 18.97M |
December 31, 2017 | 10.48M |
September 30, 2017 | 10.74M |
June 30, 2017 | 9.277M |
March 31, 2017 | 7.405M |
December 31, 2016 | 7.538M |
September 30, 2016 | 7.942M |
June 30, 2016 | 8.302M |
March 31, 2016 | 8.063M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
24.45M
Minimum
Jun 2019
55.16M
Maximum
Jun 2023
40.54M
Average
41.46M
Median
Dec 2021
SG&A Expense (Quarterly) Benchmarks
Dynavax Technologies Corp | 41.28M |
Pacira BioSciences Inc | 65.80M |
Supernus Pharmaceuticals Inc | 81.28M |
Esperion Therapeutics Inc | 45.42M |
Deciphera Pharmaceuticals Inc | 39.15M |